S Kaul Selected Research

S Kaul Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2000
6	Breast Neoplasms (Breast Cancer) 11/2004 - 02/2000
5	Inflammation (Inflammations) 11/2006 - 02/2000
4	Stroke (Strokes) 08/2011 - 09/2008
4	Pathologic Constriction (Stenosis) 01/2011 - 04/2001
4	Coronary Stenosis (Coronary Artery Stenosis) 12/2001 - 05/2000
4	Thrombosis (Thrombus) 09/2001 - 02/2000
4	Myocardial Infarction 12/2000 - 06/2000
4	Coronary Artery Disease (Coronary Atherosclerosis) 12/2000 - 02/2000
3	Hypersensitivity (Allergy) 03/2012 - 01/2002
3	Ischemic Stroke 07/2010 - 09/2008
3	Infections 07/2007 - 03/2001
2	Body Weight (Weight, Body) 08/2012 - 03/2001
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2010 - 10/2000
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2008 - 06/2004
2	Atherosclerosis 12/2001 - 06/2001
2	Hyperemia 12/2001 - 11/2001
2	Ischemia 11/2000 - 02/2000
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Agranulocytosis (Granulocytopenia) 01/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 04/2012
1	Postoperative Pain 01/2011
1	Gallstones (Gallstone) 01/2011
1	Patent Ductus Arteriosus 01/2011
1	Nervous System Diseases (Neurological Disorders) 07/2010
1	Heart Failure 06/2009
1	Chronic Renal Insufficiency 06/2009
1	Respiratory Insufficiency (Respiratory Failure) 10/2008
1	Muscular Diseases (Myopathy) 04/2007
1	Parkinson Disease (Parkinson's Disease) 12/2003
1	Mycoses (Diseases, Fungus) 03/2002
1	HIV Infections (HIV Infection) 03/2002
1	Atherosclerotic Plaque (Atheroma) 12/2001
1	Hypercapnia 11/2001
1	Hypocapnia 11/2001
1	Left Ventricular Dysfunction 11/2001

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 11/2009 - 05/2001
4	Adenosine (Adenocard)FDA LinkGeneric 12/2001 - 04/2001
3	AllergensIBA 03/2012 - 01/2002
3	LipidsIBA 12/2001 - 02/2000
3	MagnesiumIBA 09/2001 - 08/2000
3	Messenger RNA (mRNA)IBA 01/2001 - 01/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 02/2000
2	Immunoglobulin A (IgA)IBA 11/2009 - 09/2008
2	Immunoglobulin G (IgG)IBA 11/2009 - 09/2008
2	P-SelectinIBA 11/2006 - 08/2000
2	Contrast MediaIBA 11/2006 - 02/2000
2	oxidized low density lipoproteinIBA 12/2001 - 10/2000
2	AntigensIBA 05/2001 - 02/2000
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2000 - 02/2000
1	Dapsone FDA Link 01/2021
1	Abatacept (Orencia)FDA Link 08/2012
1	SaltsIBA 04/2012
1	TeaIBA 04/2012
1	N-(3-pyridyl)-3-phenylsuccinimideIBA 03/2012
1	Matrix Metalloproteinases (MMPs)IBA 08/2011
1	CausticsIBA 01/2011
1	ZincIBA 07/2010
1	CopperIBA 07/2010
1	Trace Elements (Biometals)IBA 07/2010
1	CalciumIBA 07/2010
1	IronIBA 07/2010
1	Biomarkers (Surrogate Marker)IBA 06/2009
1	Natriuretic PeptidesIBA 06/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2009
1	pro-brain natriuretic peptide (1-76)IBA 06/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2007
1	DystrophinIBA 04/2007
1	EpitopesIBA 07/2005
1	Cytidine Diphosphate (CDP)IBA 10/2004
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2004
1	Bronchodilator Agents (Bronchodilators)IBA 06/2004
1	Salmeterol Xinafoate (Serevent)FDA Link 06/2004
1	PesticidesIBA 12/2003
1	Phosphotransferases (Kinase)IBA 12/2003
1	DieldrinIBA 12/2003
1	Fluconazole (Zonal)FDA LinkGeneric 03/2002
1	Didanosine (Videx)FDA LinkGeneric 03/2002
1	Itraconazole (Sporanox)FDA LinkGeneric 03/2002
1	Immunoglobulin E (IgE)IBA 01/2002
1	Apolipoproteins E (ApoE)IBA 12/2001
1	ameroidIBA 11/2001
1	Hemostatics (Antihemorrhagics)IBA 09/2001

Therapy/Procedure

6	Microbubbles 11/2006 - 02/2000
5	Therapeutics 01/2022 - 10/2000
3	Drug Therapy (Chemotherapy) 11/2004 - 01/2000
2	Neoadjuvant Therapy 01/2022 - 02/2000
2	Injections 05/2001 - 05/2000
1	Withholding Treatment 01/2020
1	Immunotherapy 03/2012
1	Cholecystectomy 01/2011
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2011
1	Vagotomy 01/2011
1	Laparoscopic Cholecystectomy 01/2011
1	Noninvasive Ventilation 10/2008
1	Stem Cell Transplantation 11/2004
1	Craniotomy 11/2001
1	Microspheres (Microsphere) 11/2001